Polyphenol intake and mortality risk: a re-analysis of the PREDIMED trial


BACKGROUND Polyphenols may lower the risk of cardiovascular disease (CVD) and other chronic diseases due to their antioxidant and anti-inflammatory properties, as well as their beneficial effects on blood pressure, lipids and insulin resistance. However, no previous epidemiological studies have evaluated the relationship between the intake of total polyphenols intake and polyphenol subclasses with overall mortality. Our aim was to evaluate whether polyphenol intake is associated with all-cause mortality in subjects at high cardiovascular risk. METHODS We used data from the PREDIMED study, a 7,447-participant, parallel-group, randomized, multicenter, controlled five-year feeding trial aimed at assessing the effects of the Mediterranean Diet in primary prevention of cardiovascular disease. Polyphenol intake was calculated by matching food consumption data from repeated food frequency questionnaires (FFQ) with the Phenol-Explorer database on the polyphenol content of each reported food. Hazard ratios (HR) and 95% confidence intervals (CI) between polyphenol intake and mortality were estimated using time-dependent Cox proportional hazard models. RESULTS Over an average of 4.8 years of follow-up, we observed 327 deaths. After multivariate adjustment, we found a 37% relative reduction in all-cause mortality comparing the highest versus the lowest quintiles of total polyphenol intake (hazard ratio (HR) = 0.63; 95% CI 0.41 to 0.97; P for trend = 0.12). Among the polyphenol subclasses, stilbenes and lignans were significantly associated with reduced all-cause mortality (HR =0.48; 95% CI 0.25 to 0.91; P for trend = 0.04 and HR = 0.60; 95% CI 0.37 to 0.97; P for trend = 0.03, respectively), with no significant associations apparent in the rest (flavonoids or phenolic acids). CONCLUSIONS Among high-risk subjects, those who reported a high polyphenol intake, especially of stilbenes and lignans, showed a reduced risk of overall mortality compared to those with lower intakes. These results may be useful to determine optimal polyphenol intake or specific food sources of polyphenols that may reduce the risk of all-cause mortality. CLINICAL TRIAL REGISTRATION ISRCTN35739639.

DOI: 10.1186/1741-7015-12-77

Extracted Key Phrases

7 Figures and Tables

Citations per Year

118 Citations

Semantic Scholar estimates that this publication has 118 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@inproceedings{TresserraRimbau2014PolyphenolIA, title={Polyphenol intake and mortality risk: a re-analysis of the PREDIMED trial}, author={Anna Tresserra-Rimbau and Eric B . Rimm and Alexander Medina-Rem{\'o}n and Miguel A Mart{\'i}nez-Gonz{\'a}lez and Mar{\'i}a del Carmen L{\'o}pez-Sabater and Maria-Isabel Covas and Dolores Corella and Jordi Salas-Salvad{\'o} and Enrique G{\'o}mez-Gracia and Jos{\'e} Lapetra and Fernando Ar{\'o}s and Miguel Angel Fiol and Emilio Ros and Llu{\'i}s Serra-Majem and Xavier Pint{\'o} and Miguel Angel Mu{\~n}oz and Alfredo Gea and Valentina Ru{\'i}z-Guti{\'e}rrez and Ram{\'o}n Estruch and Rosa-Mar{\'i}a Lamuela-Ravent{\'o}s}, booktitle={BMC medicine}, year={2014} }